XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Redeemable convertible preferred stock
Balance at beginning of period, Redeemable convertible preferred stock (in shares) at Dec. 31, 2020           412,742,897
Balance at beginning of period, Redeemable convertible preferred stock at Dec. 31, 2020           $ 2,180
Balance at end of period, Redeemable convertible preferred stock (in shares) at Sep. 30, 2021           0
Balance at end of period, Redeemable convertible preferred stock at Sep. 30, 2021           $ 0
Balance at beginning of period, Common stock (in shares) at Dec. 31, 2020 [1]   229,031,546        
Balance at beginning of period at Dec. 31, 2020 $ (55) $ 0 [1] $ 134 $ 1 $ (190)  
Increase (decrease) in stockholder's equity            
Net loss (3,264)       (3,264)  
Shares issued in connection with stock option exercise, net of repurchases (in shares) [1]   5,816,855        
Shares issued in connection with stock option exercise, net of repurchases 13   13      
Issuance of common stock in connection with initial public offering, net of issuance costs (in shares) [1]   56,729,194        
Issuance of common stock in connection with initial public offering, net of issuance costs 2,052   2,052      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares) [1]   13,759,434        
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (412)   (412)      
Conversion of preferred stock to common stock (in shares)   412,742,897 [1]       (412,742,897)
Conversion of preferred stock to common stock 2,180   2,180     $ (2,180)
Conversion of convertible notes to common stock (in shares) [1]   137,305,156        
Conversion of convertible notes to common stock 5,218   5,218      
Reclassification of warrant liability to stockholders' equity 380   380      
Change in other comprehensive income 0          
Share-based compensation 1,272   1,272      
Balance at end of period, Common stock (in shares) at Sep. 30, 2021 [1],[2]   855,385,082        
Balance at end of period at Sep. 30, 2021 7,384 $ 0 [1],[2] 10,837 1 (3,454)  
Balance at beginning of period, Redeemable convertible preferred stock (in shares) at Jun. 30, 2021           412,742,897
Balance at beginning of period, Redeemable convertible preferred stock at Jun. 30, 2021           $ 2,180
Balance at end of period, Redeemable convertible preferred stock (in shares) at Sep. 30, 2021           0
Balance at end of period, Redeemable convertible preferred stock at Sep. 30, 2021           $ 0
Balance at beginning of period, Common stock (in shares) at Jun. 30, 2021 [2]   232,609,957        
Balance at beginning of period at Jun. 30, 2021 (1,985) $ 0 [2] 151 1 (2,137)  
Increase (decrease) in stockholder's equity            
Net loss (1,317)       (1,317)  
Shares issued in connection with stock option exercise, net of repurchases (in shares) [2]   2,238,444        
Shares issued in connection with stock option exercise, net of repurchases 6   6      
Issuance of common stock in connection with initial public offering, net of issuance costs (in shares) [2]   56,729,194        
Issuance of common stock in connection with initial public offering, net of issuance costs 2,052   2,052      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares) [2]   13,759,434        
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (412)   (412)      
Conversion of preferred stock to common stock (in shares)   412,742,897 [2]       (412,742,897)
Conversion of preferred stock to common stock 2,180   2,180     $ (2,180)
Conversion of convertible notes to common stock (in shares) [2]   137,305,156        
Conversion of convertible notes to common stock 5,218   5,218      
Reclassification of warrant liability to stockholders' equity 380   380      
Change in other comprehensive income 0          
Share-based compensation 1,262   1,262      
Balance at end of period, Common stock (in shares) at Sep. 30, 2021 [1],[2]   855,385,082        
Balance at end of period at Sep. 30, 2021 7,384 $ 0 [1],[2] 10,837 1 (3,454)  
Balance at beginning of period, Redeemable convertible preferred stock (in shares) at Dec. 31, 2021           0
Balance at beginning of period, Redeemable convertible preferred stock at Dec. 31, 2021           $ 0
Balance at end of period, Redeemable convertible preferred stock (in shares) at Sep. 30, 2022           0
Balance at end of period, Redeemable convertible preferred stock at Sep. 30, 2022           $ 0
Balance at beginning of period, Common stock (in shares) at Dec. 31, 2021   863,912,613        
Balance at beginning of period at Dec. 31, 2021 7,293 $ 0 11,169 1 (3,877)  
Increase (decrease) in stockholder's equity            
Net loss (862)       (862)  
Shares issued in connection with stock option exercise, net of repurchases (in shares)   2,152,493        
Shares issued in connection with stock option exercise, net of repurchases 6   6      
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)   1,529,727        
Issuance of common stock in connection with Employee Stock Purchase Plan 13   13      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares)   17,118,956        
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (9)   (9)      
Change in other comprehensive income (2)     (2)    
Share-based compensation 515   515      
Balance at end of period, Common stock (in shares) at Sep. 30, 2022   884,713,789        
Balance at end of period at Sep. 30, 2022 6,954 $ 0 11,694 (1) (4,739)  
Balance at beginning of period, Redeemable convertible preferred stock (in shares) at Jun. 30, 2022           0
Balance at beginning of period, Redeemable convertible preferred stock at Jun. 30, 2022           $ 0
Balance at end of period, Redeemable convertible preferred stock (in shares) at Sep. 30, 2022           0
Balance at end of period, Redeemable convertible preferred stock at Sep. 30, 2022           $ 0
Balance at beginning of period, Common stock (in shares) at Jun. 30, 2022   878,257,164        
Balance at beginning of period at Jun. 30, 2022 7,017 $ 0 11,581 0 (4,564)  
Increase (decrease) in stockholder's equity            
Net loss (175)       (175)  
Shares issued in connection with stock option exercise, net of repurchases (in shares)   289,539        
Shares issued in connection with stock option exercise, net of repurchases 1   1      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares)   6,437,108        
Shares withheld related to net share settlement (in shares)   (270,022)        
Shares withheld related to net share settlement (2)   (2)      
Change in other comprehensive income (1)     (1)    
Share-based compensation 114   114      
Balance at end of period, Common stock (in shares) at Sep. 30, 2022   884,713,789        
Balance at end of period at Sep. 30, 2022 $ 6,954 $ 0 $ 11,694 $ (1) $ (4,739)  
[1] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. Refer to Note 1 of the Annual Report on Form 10-K for the year ended December 31, 2021 for more information.
[2] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering , all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. Refer to Note 1 of the Annual Report on Form 10-K for the year ended December 31, 2021 for more information.